Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Holtappels, Rafaela; Podlech, Juergen; Lemmermann, Niels A. W. et al.
Non-cognate bystander cytolysis by clonal epitope-specific CTL lines through CD28-CD80 interaction inhibits antibody production: A potential caveat to CD8 T-cell immunotherapyCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 44-56
Andlauer, Till F. M.; Buck, Dorothea; Antony, Gisela et al.
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulationSCIENCE ADVANCES. Bd. 2. H. 6. 2016
Krebs, F.; Hahn, S.; Mitzel, H. et al.
Novel prognostic marker proteins for malignant melanoma immunotherapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 23-23
Schwartz, Christian; Eberle, Joerg U.; Hoyler, Thomas et al.
Opposing functions of thymic stromal lymphopoietin-responsive basophils and dendritic cells in a mouse model of atopic dermatitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 138. H. 5. 2016 S. 1443-+
Backes, Christina; Ludwig, Nicole; Leidinger, Petra et al.
Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascadesONCOTARGET. Bd. 7. H. 44. 2016 S. 71514-71525
Bedoui, Sammy; Gebhardt, Thomas; Gasteiger, Georg et al.
Parallels and differences between innate and adaptive lymphocytesNATURE IMMUNOLOGY. Bd. 17. H. 5. 2016 S. 490-494
Dietze-Schwonberg, Kirsten; Lorenz, Beate; Kostka, Susanna Lopez et al.
Parasite Clearance in Leishmaniasis in Resistant Animals Is Independent of the IL-23/IL-17A AxisJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 136. H. 9. 2016 S. 1906-1908
Waisman, Ari; Hoevelmeyer, Nadine; Diefenbach, Andreas et al.
Past, present and future of immunology in MainzCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 1-6
Luangmonkong, Theerut; Weymaere, Jana; Suriguga, Su et al.
Pathophysiologic model of non-alcoholic fatty liver disease using precision-cut liver slicesHEPATOLOGY. Bd. 63. H. 1 SUPP. 2016 S. 786A-786A
Distler, Eva; Albrecht, Jana; Brunk, Ariane et al.
Patient-individualized CD8(+) cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient miceINTERNATIONAL JOURNAL OF CANCER. Bd. 138. H. 5. 2016 S. 1256-1268